Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
05/11/1994 | WO1994010150A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aβ)-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF |
05/11/1994 | WO1994010127A1 Tartronic acids, their acetalic ethers and o-esters |
05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
05/11/1994 | WO1994009813A1 Method for treatment or prevention of obesity |
05/11/1994 | WO1994009789A1 USE OF 17α-DIHYDROEQUILENIN FOR LOWERING CHOLESTEROL |
05/11/1994 | EP0596717A1 Nutritional supplement for the elderly |
05/11/1994 | EP0596326A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production |
05/11/1994 | EP0596026A1 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
05/11/1994 | CA2148693A1 Tartronic acids, their acetalic ethers and o-esters |
05/11/1994 | CA2148357A1 Use of 17.alpha.-dihydroequilenin for lowering cholesterol |
05/11/1994 | CA2148002A1 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-trimethyl-(8a.beta.)-6- isoquino lineamine derivatives, preparation method therefor and therapeutical usethereof |
05/11/1994 | CA2147494A1 Intrinsic inhibitors of aldose reductase |
05/10/1994 | US5310930 Cyclization of the carboximidate salt |
05/10/1994 | US5310763 Hydroxamino acid based collagenase inhibitors |
05/10/1994 | US5310757 3,3,5-trimethylcyclohexyl 2-methylpropionate derivatives, their method of preparation and therapeutic compositions in which they are present |
05/10/1994 | US5310740 Renin inhibitors |
05/06/1994 | CA2109392A1 Composition and method for reducing the risk of hypotension |
05/04/1994 | EP0595635A1 Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors |
05/04/1994 | EP0595576A2 Stabilized sorbic acid or salt thereof |
05/04/1994 | EP0595467A2 Process for preparing antifolate 4-hydroxypyrrolo 2,3-d pyrimidine derivatives |
05/04/1994 | EP0595183A1 Hydantoin derivatives, salts thereof and maillard reaction inhibitors comprising the same |
05/04/1994 | EP0595006A1 Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
05/04/1994 | EP0595005A1 Pharmaceutical preparations for lowering homocysteine levels, containing vitamin B6, folic acid and vitamin B12 |
05/04/1994 | EP0594999A1 Phospholipid derivatives containing higher elements of the fifth main group |
05/04/1994 | EP0594612A1 A substance for lowering high cholesterol level in serum and a method for preparing the same. |
05/04/1994 | EP0594602A1 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
05/04/1994 | EP0594570A1 Preparations containing colestyramine for reducing lipid levels. |
05/04/1994 | EP0515456B1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them |
05/04/1994 | CN1086217A Phosphinyloxy propanaminium inner salt derivatives |
05/04/1994 | CN1086102A A nutritive composition and a process for its production |
05/03/1994 | US5308864 Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A |
05/03/1994 | US5308856 Thiazolidine-2,4-dione derivatives, salts and preparation processes thereof |
05/03/1994 | US5308844 Antidepressant, anxiolytic agent, analgesic, hypotensive agent |
05/03/1994 | US5308832 Nutritional product for persons having a neurological injury |
05/03/1994 | US5308627 Nutritional supplement for optimizing cellular health |
05/03/1994 | US5308618 Dietary fiber extracted from wheat bran pharmaceutical and dietary compositions containing same |
05/03/1994 | CA1329195C Steroids useful as anti-cancer and anti-obesity agents |
05/01/1994 | WO1994010181A1 Methanediphosphonate derivative, process for producing the same, and pharmaceutical use thereof |
04/29/1994 | CA2107644A1 .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd |
04/28/1994 | WO1994009147A1 Fo-1289 substance and its production |
04/28/1994 | WO1994009120A1 Retroviral mediated transfer of the human multiple drug resistance gene |
04/28/1994 | WO1994009037A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
04/28/1994 | WO1994008606A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
04/28/1994 | WO1994008583A1 Benzo-fused lactams promote release of growth hormone |
04/28/1994 | WO1994008573A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
04/28/1994 | WO1994008548A1 Transfusion liquid-containing holder and prepared transfusion liquid |
04/28/1994 | CA2147599A1 Container filled with infusion liquids and infusion preparation |
04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
04/28/1994 | CA2147167A1 A new class of rptpases: their structural domains and ligands |
04/28/1994 | CA2146929A1 Retroviral mediated transfer of the human multiple drug resistance gene |
04/28/1994 | CA2145863A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
04/28/1994 | CA2144764A1 Benzo-fused lactams promote release of growth hormone |
04/27/1994 | EP0593857A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
04/27/1994 | EP0505565B1 Quinoline derivatives, their production and use |
04/27/1994 | EP0460034B1 Novel vitamin d analogues |
04/27/1994 | EP0460032B1 Novel vitamin d analogues |
04/27/1994 | CN1085913A Glucagon-like peptide and insulinotropin derivatives |
04/27/1994 | CN1085909A Novel quaternary nitrogen containing phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
04/27/1994 | CN1085907A Novel thio-substituted, nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
04/27/1994 | CN1024347C Prepn. of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains |
04/27/1994 | CN1024346C Antihypertensive 3-piperidinyl-indazole derivatives |
04/26/1994 | US5306817 Process for the stereospecific synthesis of azetidinones |
04/26/1994 | US5306726 Antidiabetic agents |
04/26/1994 | US5306710 Method for treating endotoxin shock with CRF |
04/26/1994 | CA1328878C Antihypercholesterolemic agents |
04/26/1994 | CA1328877C Antihypercholesterolemic agents |
04/26/1994 | CA1328876C 5-oxygenated hmg-coa reductase inhibitors |
04/26/1994 | CA1328873C Hypoglycemic thiazolidinedione derivatives |
04/26/1994 | CA1328872C Thiazolidinedione hypoglycemic agents |
04/20/1994 | EP0593348A1 Thiazolidine dione derivatives, process for their preparation and pharmaceutical compositions containing them |
04/20/1994 | EP0592594A1 Colestipol hydrochloride high-content tablets |
04/20/1994 | EP0592439A1 Aminosulfonyl carbamates |
04/20/1994 | CN1085561A Steroidal glycosides for treating hypercholesterolemia |
04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
04/19/1994 | US5304575 Use of bezafibrate for treating diabetes |
04/19/1994 | US5304562 17β-substituted Aza-androstane derivatives |
04/19/1994 | US5304557 Substituted oxoophthalazinyl acetic acids and analogs thereof |
04/19/1994 | US5304473 Treating non-insulin dependent diabetes |
04/19/1994 | US5304379 A reservoir consists of tetracaine and metabolic modulator to inhibit monoamine oxidase enzyme |
04/14/1994 | WO1994007867A1 Substituted pyrimidines for control of diabetic complications |
04/14/1994 | WO1994007853A1 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
04/14/1994 | WO1994007852A1 Novel vitamin d analogues |
04/14/1994 | WO1994007851A1 Novel vitamin d analogues |
04/14/1994 | WO1994007830A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
04/14/1994 | WO1994007514A1 Pulmonary delivery of active fragments of parathyroid hormone |
04/14/1994 | WO1994007495A1 Use of norastemizole for the treatment of allergic disorders |
04/14/1994 | WO1994007486A1 Benzo-fused lactams promote release of growth hormone |
04/14/1994 | WO1994007378A1 Food additive and use thereof |
04/14/1994 | WO1993010804A1 Cosmetic or pharmaceutical composition containing a black horehound extract |
04/14/1994 | CA2145418A1 Pulmonary delivery of active fragments of parathyroid hormone |
04/14/1994 | CA2142706A1 Benzo-fused lactams promote release of growth hormone |
04/14/1994 | CA2136451A1 Novel vitamin d analogues |
04/14/1994 | CA2124555A1 Cosmetic or pharmaceutical composition containing a black horehound extract |
04/13/1994 | EP0591937A1 Use of isoquinolinone derivatives for treating hyperlipoproteinemia |
04/13/1994 | EP0591857A1 Use of L-carnitine and acyl L-carnitines for the long-term treatment of non-insulin-dependent diabetic patients |
04/13/1994 | EP0591458A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
04/13/1994 | EP0591408A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |